Director Harjit Gill filed a Form 4 with the SEC on November 13, 2026, disclosing a disposition of ResMed Inc common stock on November 11, 2026, related to the vesting of Restricted Stock Units.
Key Highlights
- Reporting person: Harjit Gill, identified as a Director of ResMed Inc (NYSE:RMD)
- Transaction date: November 11, 2026
- Transaction code F: 35.731 shares of ResMed Common Stock disposed of to the issuer for tax withholding
- Price per share: $234.11
- RSU grant date: The filing states the RSUs were granted on November 20, 2025
- Remaining beneficial ownership: 10,904 shares of ResMed Common Stock held directly following the transaction
Harjit Gill's Tax Withholding Disposition on RSU Vesting
According to the filing, Director Harjit Gill disposed of 35.731 shares of ResMed Common Stock on November 11, 2026, using transaction code F, which the filing's footnote describes as a "Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025." The shares were disposed of at a price of $234.11 per share. The filing indicates this was a direct ownership transaction.
Following the reported transaction, the filing states that Gill directly holds 10,904 shares of ResMed Common Stock. The Form 4 was filed on November 13, 2026, and covers only Gill as a single reporting person. No derivative securities transactions were reported in Table II of the filing.
The filing was signed by Harjit Gill in the capacity of Director on November 13, 2026. No indication is given in the filing that the transaction was made pursuant to a Rule 10b5-1(c) written plan, as the corresponding checkbox was not marked.
What Was Disclosed
ResMed Inc director Harjit Gill reported a disposition of 35.731 shares of common stock at $234.11 per share on November 11, 2026, to cover tax withholding obligations upon the vesting of Restricted Stock Units originally granted November 20, 2025, leaving Gill with 10,904 directly held shares.




Please wait processing your request...